Compare ODTX & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODTX | ELVR |
|---|---|---|
| Founded | 2021 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2025 | 2018 |
| Metric | ODTX | ELVR |
|---|---|---|
| Price | $16.85 | $20.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $34.67 | N/A |
| AVG Volume (30 Days) | ★ 291.0K | 66.2K |
| Earning Date | 11-04-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $40.12 |
| Revenue Next Year | N/A | $16.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.10 | $21.32 |
| 52 Week High | $29.05 | $102.80 |
| Indicator | ODTX | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 36.09 | 32.35 |
| Support Level | $15.73 | N/A |
| Resistance Level | $19.60 | $27.99 |
| Average True Range (ATR) | 1.69 | 1.25 |
| MACD | -0.19 | 0.31 |
| Stochastic Oscillator | 6.10 | 6.09 |
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is lithium mining and processing at North American Lithium(NAL) and ongoing identification, evaluation and development of its world-wide portfolio of mineral exploration assets, predominantly focusing on lithium. Its segments are North American Lithium, and All other operations. Majority of revenue comes from North American Lithium. It has presence in China, and USA. Majority of revenue comes from China.